🕒 Wednesday 23 July 2025 Wed, 23 July 2025
122 Articles
Invex Therapeutics Expands Alzheimer’s Research and Secures Orphan Drug Renewals
Invex Therapeutics has broadened its collaboration with Tessara Therapeutics to explore Exenatide’s potential in Alzheimer’s disease, while successfully renewing key orphan drug designations in Europe and the US.
23 July
Bastion Minerals and GTT Ventures Settle Legal Dispute, Writ Withdrawn
Bastion Minerals and former advisor GTT Ventures have resolved their legal dispute, leading to the withdrawal of a writ that had cast uncertainty over the company.
23 July
